Home/Pipeline/EBC-1013

EBC-1013

Venous leg ulcers (chronic wounds)

Phase 1Active

Key Facts

Indication
Venous leg ulcers (chronic wounds)
Phase
Phase 1
Status
Active
Company

About Qbiotics

Australian biotech leveraging rainforest‑derived small molecules for oncology and wound‑healing therapies.

View full company profile

Therapeutic Areas